Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

5.45

+0.21 (4.01%)

At close: Aug 14, 2026, 4:00 PM EDT

5.44

-0.01 (-0.24%)

After-hours: Aug 14, 2026, 7:37 PM EDT

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	2,700	8,426	44	300	450	-
Market Cap Growth	-59.31%	19171.44%	-85.42%	-33.42%	-	-
Enterprise Value	2,698	8,418	39	284	452	-
Last Close Price	5.45	17.04	0.09	0.61	0.91	-
PB Ratio	2214.51	1733.67	5.32	25.01	26.36	-
P/TBV Ratio	2214.51	1733.67	5.32	24.92	26.39	-
Debt / Equity Ratio	0.32	0.11	0.01	0.04	0.05	-0.92
Net Debt / Equity Ratio	-1.62	-0.90	-0.96	-0.93	-0.92	-0.91
Net Debt / EBITDA Ratio	0.28	1.18	1.78	1.86	2.10	-2.67
Net Debt / FCF Ratio	0.47	1.33	1.97	2.23	2.59	-4.72
Quick Ratio	1.42	7.38	41.13	19.06	28.42	0.01
Current Ratio	1.42	7.39	41.92	19.15	28.46	0.02
Return on Equity (ROE)	-177.66%	-54.81%	-43.18%	-41.71%	-116.10%	-
Return on Assets (ROA)	-84.97%	-33.20%	-28.11%	-25.59%	-51.87%	-202.15%
Return on Capital Employed (ROCE)	-529.30%	-74.00%	-57.50%	-52.20%	-43.70%	34.60%
Earnings Yield	-0.26%	-0.04%	-9.84%	-1.96%	-1.65%	-
FCF Yield	-0.15%	-0.04%	-9.16%	-1.66%	-1.34%	-
Buyback Yield / Dilution	-	-	-	-1.62%	-28.06%	-

SEC Filings: 10-K · 10-Q